Akebia Therapeutics, Inc.

AKBA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001517022

SEC filings (opens in a new tab)

No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Akebia Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of AKBA: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	103	1	114	+12
Shares	56.3M	11.6M	59.4M	+14.8M (+33.1%)
Value	$57.4M	$11.9M	$78.4M	+$32.9M (+72.2%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Akebia Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AKBA in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	15,197,207	$20.1M	0.00%
Wellington Management Group LLP	404,718	$534.2K	0.00%
Franklin Resources Inc	167,184	$220.7K	0.00%
AQR Capital Management LLC	141,049	$186.2K	0.00%
ExodusPoint Capital Management, LP	133,934	$177.0K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	114,148	$150.7K	0.00%
Deutsche Bank AG	110,385	$145.7K	0.00%
D. E. Shaw & Co., Inc.	82,961	$109.5K	0.00%
Manufacturers Life Insurance Company, The	78,444	$103.5K	0.00%
HSBC Holdings PLC	54,973	$72.6K	0.00%
CWA Asset Management Group, LLC	49,000	$64.7K	0.00%
Intech Investment Management LLC	45,066	$59.5K	0.00%
XTX Topco Ltd	44,267	$58.4K	0.00%
ProShare Advisors LLC	39,308	$51.9K	0.00%
GTS Securities LLC	34,389	$45.4K	0.00%
Empirical Asset Management, LLC	33,700	$44.5K	0.02%
Two Sigma Investments, LP	24,848	$32.8K	0.00%
US Bancorp	17,624	$23.3K	0.00%
Atom Investors LP	14,567	$19.2K	0.00%
Two Sigma Securities, LLC	13,309	$17.6K	0.00%
Group One Trading, L.P.	12,306	$16.2K	0.00%
Quantbot Technologies LP	2,116	$2.79K	0.00%
Jones Financial Companies LLLP	1,000	$1.33K	0.00%
Truvestments Capital LLC	756	$998	0.00%
Sterling Capital Management LLC	619	$817	0.00%
Nisa Investment Advisors, LLC	600	$792	0.00%
Capital Performance Advisors LLP	68	$90	0.00%

Sold out (15)

Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of AKBA in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Acadian Asset Management LLC	4,063,383	$4.14M
Marshall Wace, LLP	247,069	$252.0K
Citadel Advisors LLC	214,669	$219.0K
Assenagon Asset Management S.A.	211,647	$215.9K
Balyasny Asset Management LLC	129,896	$132.5K
Graham Capital Management, L.P.	57,624	$58.8K
Marathon Trading Investment Management LLC	52,651	$53.7K
Edmond de Rothschild Holding S.A.	50,000	$51.0K
Envestnet Asset Management Inc	16,500	$16.8K
Sykon Capital LLC	15,000	$15.3K
Colony Group, LLC	10,575	$14.0K
GWM Advisors LLC	2,535	$2.59K
Redwood Wealth Management Group, LLC	300	$306
Laurel Wealth Advisors LLC	229	$234
Headlands Technologies LLC	208	$212

Not filed for Q3 2024 yet (1)

Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AKBA in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	11,638,484	$11.9M